Latest Embryonic stem cell Stories

When an embryonic stem cell is in the first stage of its development it has the potential to grow into any type of cell in the body, a state scientists call undifferentiated. A team of researchers from Scotland has now demonstrated a way to easily distinguish undifferentiated embryonic stem cells from later-stage stem cells whose fate is sealed. The results are published in the American Institute of Physics' (AIP) journal Biomicrofluidics. The researchers used an electric field to pull stem...

MADISON, Wis., Jan. 3, 2013 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI) today announced a Center of Excellence agreement with AstraZeneca to accelerate the pace of drug discovery through the use of human induced pluripotent stem cell (iPSC) lines and tissue cells. iPSC technology, based on reprogramming adult cells from a simple blood sample or a skin biopsy to a pluripotent stem cell state, shows promise in delivering robust human cell models of high utility in drug...

Centagen has developed a breakthrough stem cell therapy that rejuvenates a patient's own adult stem cells. The Company has found a way to expand a patient’s own stem cells in the lab millions of times while rejuvenating the cells. For example, a patient’s blood pleuropotent stem cells could be rejuvenated and expanded in the lab and then re-injected to repair and rejuvenate organs and tissues damaged by aging or disease. Centagen has announced a funding campaign at...

Connie K. Ho for redOrbit.com – Your Universe Online Scientists from the Stowers Institute for Medical Research recently completed a study that shows the possibility that stem cells work towards maturity at an earlier stage than originally thought. In particular, the researchers believe that embryonic stem cells are different from muscle or nerve cells in their ability to take on any cellular role. With this “pluripotency,” the stem cells are flexible enough to activate highly...

Salk Institute The new method boosts cell yields and increases safety, helping to get another step closer to regenerative medicine A new method for generating stem cells from mature cells promises to boost stem cell production in the laboratory, helping to remove a barrier to regenerative medicine therapies that would replace damaged or unhealthy body tissues. The technique, developed by researchers at the Salk Institute for Biological Studies, allows for the unlimited production of...

Fraunhofer-Gesellschaft Breakthrough in heart research: The research team from Professor Katja Schenke-Layland of the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart has discovered cell surface markers that enable the identification and isolation of living functional cardiovascular progenitor cells (CPCs). For the first time, therapeutically relevant CPCs can be derived from induced-pluripotent stem cells (iPS) cells. CPCs, which are typically only found...

Scientists from The Danish Stem Cell Center (DanStem) at the University of Copenhagen are contributing important knowledge about how stem cells develop best into insulin-producing cells. In the long term this new knowledge can improve diabetes treatment with cell therapy. The results have just been published in the scientific journal Cell Reports. Stem cells are responsible for tissue growth and tissue repair after injury. Therefore, the discovery that these vital cells grow better in a...

Connie K. Ho for redOrbit.com – Your Universe Online Researchers from the Sanford-Burnham Medical Research Institute recently discovered that neurons developed from stem cells can boost brain activity following transplantation with a laboratory model. The findings show that the cells could possibly be used in the future to treat Alzheimer’s disease and other types of neurodegenerative illnesses. Currently, scientists are able to develop neurons and other brain cells from stem cells....

JERUSALEM, Nov. 12, 2012 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (OTC: HADSY, TASE: HDST) a publicly traded portfolio of biotech companies, all based on intellectual property developed by the Hadassah University Hospital, Israel's foremost medical research center, announced that its portfolio company CellCure NeuroSciences and BioTime, Inc. (NYSE MKT: BTX) have entered into a share purchase agreement through which BioTime will provide Cell Cure with $3.5 million of BioTime stock...

Caltech-led team discovers enzyme responsible for neural crest cell development During the early developmental stages of vertebrates—animals that have a backbone and spinal column, including humans—cells undergo extensive rearrangements, and some cells migrate over large distances to populate particular areas and assume novel roles as differentiated cell types. Understanding how and when such cells switch their purpose in an embryo is an important and complex goal for developmental...